Summary from the: EUCOPE-‐Pongratz Consulting-‐EURIDA workshop “En Route to Horizon 2020” Brussels 2014-‐02-‐04/05
Speakers: • Dr Alexander Natz (Chair EUCOPE) • Dr Rudolf Strohmeier (Deputy Director DG-‐Research and Innovation) • Dr Ingemar Pongratz (CEO Fenix Scientific, Pongratz Consulting) • Dr Rita Clancy (CEO Eurida Research Management) • Dr Mike Edwards (Chair EMIG) • Dr John Stringer (CEO Berkley Associates) • Dr Daniel Schubart (CEO ConsulTech)
Sessions • The EU view on Horizon 2020 and other funding schemes • Horizon 2020 structure and policy background • Horizon 2020 and Innovation, the role of SME • Societal challenges • The role of charities • Funding the research base • Rules of Participation • COSME and Access to Risk Finance • Communication and Dissemination • Practical Approach • The Life of an EU project Manager
Some findings • Horizon 2020 will support the Innovation Union and Europe 2020 objectives • There is political understanding of the link between investments in Research and Innovation and Economic Growth • New proposals regarding for example IMI will be presented to the EU Parliament soon • Horizon 2020 will look for Answers not for Technology • Horizon 2020 is Challenge driven • Time to Grant will be reduced, negotiations will be short • Impact will be a key discussion
Some findings • Charities play a key role in Innovation Transfer • Facilitators between Research and Patients • Presentations of UK models of Innovation transfer
Some Discussion Issues • Administration issues • The Simplified Model Grant Agreement is 106 pages long • Hierarchy of Rules still complex • Audits based Trust • Accredited Auditors and Audit Procedures • Simplification for whom?
Contact Information • Ingemar Pongratz • [email protected]
• Rita Clancy • r.clancy@eurida-‐research.com
Recommended
